Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01918826
Other study ID # 11-AOI-06
Secondary ID
Status Recruiting
Phase N/A
First received July 20, 2012
Last updated August 7, 2013
Start date June 2012
Est. completion date August 2013

Study information

Verified date July 2012
Source Centre Hospitalier Universitaire de Nice
Contact Cécile RIBIERE, Dr
Phone 04 92 03 55 05
Email ribiere.c@chu-nice.fr
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)France: Committee for the Protection of Personnes
Study type Interventional

Clinical Trial Summary

The Charcot syndrome Marie Tooth is the most frequent hereditary neuromuscular diseases: there is no curative treatment at present, on the other hand precautionary measures can be taken (physiotherapy, port of splints, orthopaedic surgery and technical assistants). In the literature and in our recent study (evaluation of the pain in the disease of CMT - Reference center of the neuromuscular diseases - CHU Bow) the frequency of the pain is important varying from 66 to 96 % cases, affecting especially hands and lower limbs. The care of the pain in the Charcot syndrome Marie Tooth is not codified. The transcutaneous neurostimulation(TENS) is a not medicinal and not invasive therapeutics, without any brought back collateral effect, used at the same time in the chronic pain and acute since 1960, as well for the neuropathic pains that musculo-scrawny. No study was realized this day on the use of the TENS with analgesic aim in the CMT. We suggest studying the analgesic efficiency of the TENS in the Charcot syndrome Marie Tooth on the pains of lower limbs, the most frequent painful location in our recent works.

The main objective will be to analyze the improvement of the pain of lower limbs, based on the decrease of the analogical visual scale(ladder) (EVA), at least 30 %.

The secondary objectives will be to estimate repercussions on the functional capacities ( ONLS), the quality of life (SF(sci-fi) 12), the satisfaction (EVA), the global impression(printing) of change ( PGIC), the consumption of analgesic, DN4, NPSI (Neuropathic Pain Symptom Inventory), Concise Questionnaire of the Pains ( QCD), HAD (Hospital Anxiety and Depression scale).


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date August 2013
Est. primary completion date August 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Age included between 18 and 75 years

- Affected by CMT confirmed on clinical, family criteria, electrophysiological and / or genetics

- pain = 3 months

- EVA pain = 4/10

- patient having given his written consent and lit(enlightened)

- patient susceptible to be followed regularly during at least 3 months

- Patient member to the Social Security

Exclusion Criteria:

- Expanding patients of associated neurological pathology

- Patients having resorted to the TENS in the last 3 months

- Medical history of cancers, collagen and quite other pathology which can interfere with the experimental procedure

- Patient carrier of a pacemaker or an active implantable medical device

- Cutaneous hurt on the territory to be stimulated

- Venous or arterial thrombosis or thrombophlebitis in the territory to be stimulated

- Patient participant in another biomedical research on the pain or the period of exclusion of which in a study is not ended

- Patient under guardianship or deprived of all his liberties

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Intervention

Device:
TENS


Locations

Country Name City State
France CHU de Nice Nice

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale At 3 month No
See also
  Status Clinical Trial Phase
Completed NCT02561702 - Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease Phase 2
Completed NCT00541164 - Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease Phase 1/Phase 2
Completed NCT01455623 - Development and Validation of a Disability Severity Index for CMT N/A
Completed NCT02194010 - Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)
Recruiting NCT01203085 - Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Recruiting NCT01193075 - Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others